Englewood Lab, Inc. (KOSDAQ:950140)
South Korea
· Delayed Price · Currency is KRW 12,470
+60 (0.48%)
At close: Mar 6, 2026
Englewood Lab Revenue
Englewood Lab had revenue of 63.06B KRW in the quarter ending September 30, 2025, with 54.00% growth. This brings the company's revenue in the last twelve months to 204.62B, up 3.87% year-over-year. In the year 2024, Englewood Lab had annual revenue of 182.22B, down -11.88%.
Revenue (ttm)
204.62B
Revenue Growth
+3.87%
P/S Ratio
1.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
244.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 182.22B | -24.56B | -11.88% |
| Dec 31, 2023 | 206.78B | 55.28B | 36.48% |
| Dec 31, 2022 | 151.51B | -9.31B | -5.79% |
| Dec 31, 2021 | 160.82B | 23.65B | 17.24% |
| Dec 31, 2020 | 137.17B | 3.85B | 2.89% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CLIO Cosmetics Co.,Ltd | 326.53B |
| Manyo Factory | 118.72B |
| Genic | 85.47B |
| C&C International | 271.51B |
| Raphas | 32.16B |
| Icure Pharmaceutical Incorporation | 93.22B |
| Cosmecca Korea | 590.81B |
| Coreana Cosmetics | 76.53B |